Search results
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 4 days agoThe company developed it as an easier alternative to pills. Neurocrine also had promising test...
PharmaTher Announces Assigned FDA Approval Goal Date of its Priority Original Abbreviated New Drug...
Digital Journal· 3 days agoFood and Drug Administration (the “FDA”) and assigned a Generic Drug User Fee Amendments of 2022 (“GDUFA”) goal date of October 29, 2024. As announced by the Company on April ...
Earnings call: INmune Bio optimistic on XPro and INKmune trials progress By Investing.com
Investing.com· 12 hours agoINmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company, reported its first-quarter...
The 6 Best Magnesium Supplements, According to Registered Dietitians
Men's Health via AOL· 7 days agoOverall, though, the research is mixed on whether supplements are helpful for exercise performance.”...
Progress Toward a New GAD Treatment Paradigm
FierceBiotech· 7 days agoThe month of May is Mental Health Awareness Month, and an appropriate time to shine a spotlight on a mental health disorder that has been underserved and...
Business provides psychedelic services to help with trauma, grief, depression - KVIA
ABC 7 El Paso· 6 days agoMany Americans are turning to psychedelics to manage trauma, stress or depression. A business in...
Debunking 5 common supplement myths
Stacker via AOL· 4 days agoLive It Up consulted various reputable sources like Johns Hopkins Medicine, Penn Medicine, and more to get the low-down on five common supplement myths.
NRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial Data
Morningstar· 7 days agoThe pharmaceutical company believes that demonstration of reduced akathisia in the setting of comparable antidepressant efficacy constitutes a basis for Accelerated FDA approval ...
Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at...
The Herald Journal· 5 days agoSALT LAKE CITY, May 8, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that data from the Phase 2 study of LPCN 1148 has been selected
Untreated hypothyroidism: Effects and more
Medical News Today· 3 days agoWithout treatment, hypothyroidism can lead to various medical issues, such as heart and kidney problems, nerve issues, or goiter. Low thyroid hormone...
